| Literature DB >> 34970193 |
Isabel Baenas1,2, Mikel Etxandi1, Ester Codina1, Roser Granero2,3, Fernando Fernández-Aranda1,2,4,5, Mónica Gómez-Peña1, Laura Moragas1, Sandra Rivas1, Marc N Potenza6,7,8,9, Anders Håkansson10,11, Amparo Del Pino-Gutiérrez2,12, Bernat Mora-Maltas1, Eduardo Valenciano-Mendoza1, José M Menchón1,4,5,13, Susana Jiménez-Murcia1,2,4,5.
Abstract
Background and Aims: COVID-19 pandemic and confinement have represented a challenge for patients with gambling disorder (GD). Regarding treatment outcome, dropout may have been influenced by these adverse circumstances. The aims of this study were: (a) to analyze treatment dropout rates in patients with GD throughout two periods: during and after the lockdown and (b) to assess clinical features that could represent vulnerability factors for treatment dropout.Entities:
Keywords: COVID-19; confinement; coping; dropout; gambling disorder
Year: 2021 PMID: 34970193 PMCID: PMC8712884 DOI: 10.3389/fpsyg.2021.761802
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Socio-demographics and clinical features (n=86).
| Socio-demographics |
| % | Clinical features | Mean | SD | |
|---|---|---|---|---|---|---|
| Gender | Male | 79 | 91.9% | Onset of GD (yrs.) | 31.77 | 12.67 |
| Female | 7 | 8.1% | Duration of GD (yrs.) | 6.21 | 7.78 | |
| Marital status | Single | 38 | 44.2% | Duration of treatment and follow-up (months) | 14.29 | 9.19 |
| Married - in a couple | 37 | 43.0% | 1SOGS total score | 10.73 | 3.23 | |
| Divorced - separated | 11 | 12.8% | 1DSM-5 total criteria | 7.05 | 2.11 | |
| Education | Primary/less | 39 | 45.3% | SCL-90R: Somatization | 0.95 | 0.82 |
| Secondary | 35 | 40.7% | SCL-90R: Obsess. /Compulsive | 1.21 | 0.81 | |
| University | 12 | 14.0% | SCL-90R: Interpersonal sensitivity | 1.05 | 0.85 | |
| Social position | High / mean-high | 12 | 14.0% | SCL-90R: Depressive | 1.53 | 0.95 |
| Mean | 9 | 10.5% | SCL-90R: Anxiety | 0.98 | 0.79 | |
| Mean-low | 31 | 36.0% | SCL-90R: Hostility | 0.96 | 0.88 | |
| Low | 34 | 39.5% | SCL-90R: Phobic anxiety | 0.45 | 0.75 | |
| Employment | Unemployed | 40 | 46.5% | SCL-90R: Paranoid Ideation | 0.91 | 0.76 |
| Employed | 46 | 53.5% | SCL-90R: Psychotic | 0.98 | 0.81 | |
| Age (yrs.); | 45.00 | 16.85 | SCL-90R: PST score | 1.07 | 0.71 | |
|
|
| % | SCL-90R: GSI score | 46.27 | 21.59 | |
| Gambling type | Non-strategic | 40 | 46.5% | SCL-90R: PSDI score | 1.91 | 0.64 |
| Strategic | 29 | 33.7% | TCI-R: Novelty seeking | 111.72 | 11.96 | |
| Mixed | 17 | 19.8% | TCI-R: Harm avoidance | 98.72 | 14.01 | |
| Modality | Offline | 57 | 66.3% | TCI-R: Reward dependence | 97.09 | 13.50 |
| Online | 12 | 14.0% | TCI-R: Persistence | 107.87 | 18.69 | |
| Mixed | 17 | 19.8% | TCI-R: Self-directedness | 129.92 | 19.65 | |
| Treatment | Individual | 27 | 31.4% | TCI-R: Cooperativeness | 128.98 | 15.36 |
| Group | 59 | 68.6% | TCI-R: Self-Transcendence | 59.94 | 11.77 | |
SD: standard deviation. GD: gambling disorder.
Descriptive variables related to confinement during the COVID-19 pandemic.
|
|
|
|
| ||
|---|---|---|---|---|---|
| Working | 22 | 25.6% | Non-adaptive reactions | 19 | 22.1% |
| With company | 77 | 89.5% | Non-adaptive reactions: COVID | 11 | 12.8% |
| Affected close people by COVID | 5 | 5.8% | Non-adaptive reactions: GD | 1 | 1.2% |
| COVID-related concerns | 58 | 67.4% | Non-adaptive reactions: Other | 7 | 8.1% |
| Concerns: infection risk | 35 | 40.7% | Anxiety (any type) | 22 | 25.6% |
| Concerns: uncertain future | 34 | 39.5% | Anxiety: physic | 10 | 11.6% |
| Concerns: employment | 19 | 22.1% | Anxiety: emotional | 17 | 19.8% |
| Concerns: medical treatments | 2 | 2.3% | Anxiety: motor | 6 | 7.0% |
| Concerns: other | 5 | 5.8% | Anxiety: cognitive | 16 | 18.6% |
| Adaptive reactions | 64 | 74.4% | Depression | 17 | 19.8% |
| Adaptive reactions: social | 21 | 24.4% | Family conflicts | 8 | 9.3% |
| Adaptive reactions: leisure | 30 | 34.9% | |||
| Adaptive reactions: sport | 10 | 11.6% | |||
| Adaptive reactions: routine | 25 | 29.1% | |||
| Adaptive reactions: work-studies | 5 | 5.8% |
SD: standard deviation.
Figure 1Incidence Density Rate (IDR) of Dropout during the nine-month observational period (n=86).
Figure 2Kaplan–Meier survival function to dropout (n=86).
Figure 3Incidence Density Rate (IDR) of relapse rates during the nine-month observational period (n=86).
Association between socio-demographics and dropout during two periods of the COVID-19 pandemic: during (T1) and after (T2) the lockdown.
| T1 | T2 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-dropout | Dropout | Non-dropout | Dropout | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Gender (female) | 7 | 9.0% | 0 | 0.0% | 0.377 |
| 5 | 9.3% | 2 | 8.3% | 0.895 | 0.03 | |
| Marital status (non-married) | 46 | 59.0% | 3 | 37.5% | 0.243 | 0.43 | 30 | 55.6% | 16 | 66.7% | 0.357 | 0.23 | |
| Education (low levels) | 37 | 47.4% | 2 | 25.0% | 0.225 |
| 26 | 48.1% | 11 | 45.8% | 0.850 | 0.05 | |
| Social status (low levels) | 33 | 42.3% | 1 | 12.5% |
|
| 22 | 40.7% | 11 | 45.8% | 0.674 | 0.10 | |
| Employment (unemployed) | 38 | 48.7% | 2 | 25.0% | 0.200 | 0.48 | 26 | 48.1% | 12 | 50.0% | 0.880 | 0.04 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Type | Non-strategic | 36 | 46.2% | 4 | 50.0% | 0.842 | 0.08 | 26 | 48.1% | 10 | 41.7% | 0.328 | 0.13 |
| Strategic | 27 | 34.6% | 2 | 25.0% | 0.21 | 16 | 29.6% | 11 | 45.8% | 0.34 | |||
| Mixed | 15 | 19.2% | 2 | 25.0% | 0.14 | 12 | 22.2% | 3 | 12.5% | 0.26 | |||
| Modality | Offline | 52 | 66.7% | 5 | 62.5% | 0.265 | 0.09 | 37 | 68.5% | 15 | 62.5% | 0.538 | 0.13 |
| Online | 12 | 15.4% | 0 | 0.0% |
| 9 | 16.7% | 3 | 12.5% | 0.12 | |||
| Mixed | 14 | 17.9% | 3 | 37.5% | 0.44 | 8 | 14.8% | 6 | 25.0% | 0.26 | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Age (yrs) | 44.74 | 16.67 | 47.50 | 19.61 | 0.662 | 0.15 | 45.74 | 16.59 | 42.50 | 16.97 | 0.432 | 0.19 | |
| Onset of GD (yrs) | 31.96 | 12.90 | 29.94 | 10.70 | 0.669 | 0.17 | 32.81 | 12.98 | 30.06 | 12.76 | 0.387 | 0.21 | |
| Duration of GD (yrs) | 6.47 | 8.04 | 3.63 | 3.89 | 0.327 | 0.45 | 6.80 | 8.22 | 5.75 | 7.76 | 0.599 | 0.13 | |
| Duration of treatment (months) | 15.14 | 9.17 | 6.00 | 3.59 |
|
| 18.09 | 9.16 | 8.50 | 4.66 |
|
| |
| 1SOGS total score | 10.78 | 3.29 | 10.25 | 2.66 | 0.660 | 0.18 | 10.63 | 3.29 | 11.13 | 3.34 | 0.543 | 0.15 | |
| 1DSM-5 total criteria | 7.04 | 2.18 | 7.13 | 1.25 | 0.913 | 0.05 | 7.17 | 2.25 | 6.75 | 2.03 | 0.440 | 0.19 | |
| SCL-90R: Somatization | 0.96 | 0.83 | 0.83 | 0.69 | 0.675 | 0.17 | 0.91 | 0.81 | 1.07 | 0.88 | 0.434 | 0.19 | |
| SCL-90R: Obsess. /comp. | 1.24 | 0.79 | 0.90 | 0.97 | 0.263 | 0.38 | 1.25 | 0.76 | 1.20 | 0.87 | 0.808 | 0.06 | |
| SCL-90R: Interp.sens. | 1.08 | 0.85 | 0.74 | 0.84 | 0.274 | 0.41 | 1.06 | 0.79 | 1.14 | 0.97 | 0.691 | 0.09 | |
| SCL-90R: Depressive | 1.56 | 0.94 | 1.17 | 1.06 | 0.271 | 0.39 | 1.58 | 0.90 | 1.53 | 1.05 | 0.812 | 0.06 | |
| SCL-90R: Anxiety | 1.02 | 0.80 | 0.61 | 0.58 | 0.167 |
| 1.06 | 0.76 | 0.92 | 0.89 | 0.473 | 0.17 | |
| SCL-90R: Hostility | 0.99 | 0.88 | 0.73 | 0.87 | 0.433 | 0.29 | 0.97 | 0.80 | 1.03 | 1.07 | 0.753 | 0.07 | |
| SCL-90R: Phobic anx. | 0.47 | 0.78 | 0.21 | 0.24 | 0.358 | 0.45 | 0.51 | 0.83 | 0.39 | 0.65 | 0.529 | 0.16 | |
| SCL-90R: Paranoid | 0.93 | 0.77 | 0.69 | 0.66 | 0.393 | 0.34 | 0.89 | 0.71 | 1.03 | 0.92 | 0.469 | 0.17 | |
| SCL-90R: Psychotic | 1.02 | 0.82 | 0.59 | 0.59 | 0.152 |
| 0.98 | 0.73 | 1.10 | 1.00 | 0.578 | 0.13 | |
| SCL-90R: PST score | 1.10 | 0.72 | 0.79 | 0.67 | 0.242 | 0.45 | 1.10 | 0.66 | 1.11 | 0.84 | 0.954 | 0.01 | |
| SCL-90R: GSI score | 47.27 | 21.06 | 36.50 | 25.67 | 0.181 | 0.46 | 47.50 | 19.16 | 46.75 | 25.27 | 0.886 | 0.03 | |
| SCL-90R: PSDI score | 1.94 | 0.65 | 1.69 | 0.57 | 0.304 | 0.40 | 1.97 | 0.62 | 1.86 | 0.72 | 0.492 | 0.16 | |
| TCI-R: Novelty seeking | 111.82 | 12.40 | 110.75 | 6.71 | 0.811 | 0.11 | 111.33 | 12.55 | 112.92 | 12.25 | 0.606 | 0.13 | |
| TCI-R: Harm avoidance | 98.77 | 13.65 | 98.25 | 18.29 | 0.921 | 0.03 | 99.39 | 13.23 | 97.38 | 14.74 | 0.551 | 0.14 | |
| TCI-R: Reward depend. | 96.92 | 13.32 | 98.75 | 16.02 | 0.718 | 0.12 | 98.30 | 13.57 | 93.83 | 12.46 | 0.174 | 0.34 | |
| TCI-R: Persistence | 107.82 | 18.11 | 108.38 | 25.21 | 0.937 | 0.03 | 108.17 | 19.54 | 107.04 | 14.72 | 0.802 | 0.07 | |
| TCI-R: Self-directedness | 129.15 | 19.79 | 137.38 | 17.68 | 0.262 | 0.44 | 128.89 | 18.08 | 129.75 | 23.60 | 0.861 | 0.04 | |
| TCI-R: Cooperativeness | 128.53 | 15.66 | 133.38 | 12.07 | 0.398 | 0.35 | 129.54 | 15.48 | 126.25 | 16.15 | 0.396 | 0.21 | |
| TCI-R: Self-Transcend. | 59.91 | 12.24 | 60.25 | 6.02 | 0.939 | 0.04 | 59.89 | 11.33 | 59.96 | 14.34 | 0.982 | 0.01 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Working | 20 | 25.6% | 2 | 25.0% | 0.968 | 0.01 | 14 | 25.9% | 6 | 25.0% | 0.931 | 0.02 | |
| With company | 71 | 91.0% | 6 | 75.0% | 0.158 | 0.44 | 48 | 88.9% | 23 | 95.8% | 0.322 | 0.27 | |
| Affected family environment | 4 | 5.1% | 1 | 12.5% | 0.396 | 0.27 | 2 | 3.7% | 2 | 8.3% | 0.392 | 0.20 | |
| COVID-related concerns | 53 | 67.9% | 5 | 62.5% | 0.754 | 0.11 | 37 | 68.5% | 16 | 66.7% | 0.872 | 0.04 | |
| Concerns: infection risk | 31 | 39.7% | 4 | 50.0% | 0.574 | 0.21 | 21 | 38.9% | 10 | 41.7% | 0.909 | 0.06 | |
| Concerns: uncertain future | 32 | 41.0% | 2 | 25.0% | 0.377 | 0.34 | 23 | 42.6% | 9 | 37.5% | 0.673 | 0.10 | |
| Concerns: employment | 18 | 23.1% | 1 | 12.5% | 0.492 | 0.28 | 9 | 16.7% | 9 | 37.5% |
|
| |
| Adaptive reactions | 60 | 76.9% | 4 | 50.0% |
|
| 42 | 77.8% | 18 | 75.0% | 0.788 | 0.07 | |
| Adaptive reactions: social | 19 | 24.4% | 2 | 25.0% | 0.968 | 0.01 | 14 | 25.9% | 5 | 20.8% | 0.629 | 0.12 | |
| Adaptive reactions: leisure | 27 | 34.6% | 3 | 37.5% | 0.870 | 0.06 | 20 | 37.0% | 7 | 29.2% | 0.500 | 0.17 | |
| Adaptive reactions: routines | 24 | 30.8% | 1 | 12.5% | 0.278 |
| 15 | 27.8% | 9 | 37.5% | 0.391 | 0.21 | |
| Non-adaptive reactions | 19 | 24.4% | 0 | 0.0% |
|
| 14 | 25.9% | 5 | 20.8% | 0.629 | 0.12 | |
| Anxiety | 22 | 28.2% | 0 | 0.0% |
|
| 15 | 27.8% | 7 | 29.2% | 0.900 | 0.03 | |
| Depression | 17 | 21.8% | 0 | 0.0% |
|
| 14 | 25.9% | 3 | 12.5% | 0.185 | 0.35 | |
SD: standard deviation.
.
Predictive models for the risk of dropout: stepwise logistic regression (n=86).
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
| Dropout during T1 Duration of treatment (months) | −0.341 | 0.120 | 0.005 | 0.711 | 0.561 | 0.900 |
| Dropout during T2 | ||||||
| Duration of treatment (months) | −0.349 | 0.090 | <0.001 | 0.706 | 0.592 | 0.841 |
| Dropout (during T1 or T2) | ||||||
| Duration of treatment (months) | −0.382 | 0.090 | <0.001 | 0.682 | 0.572 | 0.814 |
List of predictors: socio-demographics, variables at baseline and variables related to the confinement by COVID-19.